Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,588 | -57,591 | -39,993 | -23,677 | -9,310 |
| Depreciation Amortization | -107 | -1,270 | -1,047 | -685 | -76 |
| Accounts payable and accrued liabilities | 2,421 | 239 | 2,611 | 3,223 | 648 |
| Other Working Capital | 723 | 356 | 1,029 | 2,028 | -2,357 |
| Other Operating Activity | -318 | 4,094 | 38 | -2,121 | -293 |
| Operating Cash Flow | $-18,869 | $-54,172 | $-37,362 | $-21,232 | $-11,388 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -129,599 | -124,651 | -124,651 | -124,651 |
| PPE Investments | N/A | -95 | -95 | -91 | N/A |
| Sale Of Investment | 34,250 | 80,027 | 50,777 | 21,527 | 12,027 |
| Investing Cash Flow | $34,250 | $-49,667 | $-73,969 | $-103,215 | $-112,624 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4 | 91,636 | 91,362 | 91,191 | 91,185 |
| Other Financing Activity | 0 | -2,387 | -2,387 | -2,387 | -2,310 |
| Financing Cash Flow | $4 | $89,249 | $88,975 | $88,804 | $88,875 |
| Beginning Cash Position | 47,051 | 61,641 | 61,641 | 61,641 | 61,641 |
| End Cash Position | 62,436 | 47,051 | 39,285 | 25,998 | 26,504 |
| Net Cash Flow | $15,385 | $-14,590 | $-22,356 | $-35,643 | $-35,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,869 | -54,172 | -37,362 | -21,232 | -11,388 |
| Capital Expenditure | N/A | -95 | -95 | -91 | N/A |
| Free Cash Flow | -18,869 | -54,267 | -37,457 | -21,323 | -11,388 |